Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Mainz Biomed NV MYNZ

Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of... see more

Bullboard (NDAQ:MYNZ)

View:
Post by Trader19Swifton Nov 26, 2024 12:42pm

Trend Trading Alert: MYNZ Bouncing Off Key Levels

Trend traders should note MYNZ's support levels—it’s bouncing where bulls typically step in.
Comment by TradeVision2001on Nov 25, 2024 12:14pm

RE:Vanguard & Blackrock Holding TMO – MYNZ Next?

Big money never lies! If MYNZ is catching the eye of the giants, I’m all in. This could be the next big runner!
Post by TradeVision2001on Nov 25, 2024 12:11pm

Swing Traders’ Biotech Dream: MYNZ Catalyst Potential

Swing traders, don’t sleep on MYNZ. Those biotech catalysts can drop news and spike the chart any day.
Post by WealthSpring16on Nov 25, 2024 11:42am

Biotech Tailwinds: Sector in Focus

Biotech’s heating up, and MYNZ is looking primed to ride sector tailwinds. A strategic add for those bullish on health tech.
Post by pastafagolion Nov 23, 2024 10:59am

Why stock is droppping

They withdrew their submission from FDA for breakthrough device designation after the FDA told them to expand trials for average risk particpants.  New data to be submitted in 2025.  Lots of ...more  
Post by TradeDriver718on Nov 22, 2024 3:55pm

Mainz Biomed: Unlocking the Future of Diagnostics

With its low float and groundbreaking technology, MYNZ is a compelling play in the diagnostics space. Its ability to address an unmet global health need gives it a unique position for long-term growth ...more  
Post by pastafagolion Nov 22, 2024 10:38am

new to this company

Just looked at June 30 2024 FS.  Going concern disclosure as expected.  Used 7M in cash in 6 mos.  Had 700K at June 30.  Anyone know other than mass share dilution how they are ...more  
Post by MarketWolf2024on Nov 20, 2024 7:01am

Mainz Biomed NV (MYNZ)

I’m considering a stock to buy for a few years. I see potential because the company has serious intentions, especially after the latest news. 
Post by Vic2Trader1on Nov 19, 2024 3:05pm

$MYNZ & $TMO Partnership LFGOOO

  TMO 507.78 +6.49(+1.29%)    Volume 2,203,357 (2x avg)   Zack Analyst Highlighted Thermo Fisher $TMO NextEra Energy $NEE and Lowe's $LOW https://finance.yahoo ...more  
Post by whytestockson Oct 01, 2024 1:15pm

Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eye

Just In: $MYNZ Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025BERKELEY, Calif. and MAINZ, Germany, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed ...more  
Post by whytestockson May 28, 2024 12:30pm

Mainz Biomed to Present New Pooled Colorectal Cancer Screeni

JUST IN: $MYNZ Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting | BenzingaKey Findings: 92.3% Sensitivity for Colorectal ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities